These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12459522)

  • 1. Compound heterozygosity for the Xeroderma pigmentosum complementation group A gene associated with a mild phenotype.
    Negishi I; Kato G; Moriwaki S; Ishikawa O
    Eur J Dermatol; 2002; 12(6):536-9. PubMed ID: 12459522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
    Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
    Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of xeroderma pigmentosum group A diagnosed with a polymerase chain reaction (PCR) technique. Usefulness of PCR in the detection of point mutation in a patient with a hereditary disease.
    Kore-eda S; Tanaka T; Moriwaki S; Nishigori C; Imamura S
    Arch Dermatol; 1992 Jul; 128(7):971-4. PubMed ID: 1352672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of mutations in the human xeroderma pigmentosum group A gene and their relationships to the functional regions of the DNA damage recognition protein.
    States JC; McDuffie ER; Myrand SP; McDowell M; Cleaver JE
    Hum Mutat; 1998; 12(2):103-13. PubMed ID: 9671271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.
    Nishigori C; Zghal M; Yagi T; Imamura S; Komoun MR; Takebe H
    Am J Hum Genet; 1993 Nov; 53(5):1001-6. PubMed ID: 8105686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
    Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
    Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-based prenatal diagnosis in a Chinese family with xeroderma pigmentosum group A.
    Yang Y; Ding B; Wang K; Bu D; Tu P; Zhu X
    Br J Dermatol; 2004 Jun; 150(6):1190-3. PubMed ID: 15214909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
    Mimaki T; Tanaka K; Nagai A; Mino M
    Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
    Sato M; Nishigori C; Yagi T; Takebe H
    Mutat Res; 1996 Feb; 362(2):199-208. PubMed ID: 8596539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe neurological abnormalities associated with a mutation in the zinc-finger domain in a group A xeroderma pigmentosum patient.
    Maeda T; Sato K; Minami H; Taguchi H; Yoshikawa K
    Br J Dermatol; 1994 Oct; 131(4):566-70. PubMed ID: 7947212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of Xeroderma Pigmentosum Groups A and C by Detection of Two Prevalent Mutations in West Algerian Population: A Rapid Genotyping Tool for the Frequent XPC Mutation c.1643_1644delTG.
    Bensenouci S; Louhibi L; De Verneuil H; Mahmoudi K; Saidi-Mehtar N
    Biomed Res Int; 2016; 2016():2180946. PubMed ID: 27413738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of xeroderma pigmentosum group A in Japan.
    Moriwaki S; Yamashita Y; Nakamura S; Fujita D; Kohyama J; Takigawa M; Ohmichi M
    J Dermatol; 2012 Jun; 39(6):516-9. PubMed ID: 22168765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic heterogeneity in group A xeroderma pigmentosum.
    Mimaki T; Tanaka K; Okada Y; Minami R; Tachi N; Nagai A; Mino M
    Acta Neurol Scand; 1992 May; 85(5):327-30. PubMed ID: 1621494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients.
    Cartault F; Nava C; Malbrunot AC; Munier P; Hebert JC; N'guyen P; Djeridi N; Pariaud P; Pariaud J; Dupuy A; Austerlitz F; Sarasin A
    DNA Repair (Amst); 2011 Jun; 10(6):577-85. PubMed ID: 21482201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
    Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
    DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma pigmentosum variant: complementary molecular approaches to detect a 13 base pair deletion in the DNA polymerase eta gene.
    Hentosh P; Benjamin T; Hall L; Leap S; Loescher J; Poyner E; Sundin T; Whittle M; Wilkinson S; Peffley DM
    Exp Mol Pathol; 2011 Oct; 91(2):528-33. PubMed ID: 21640722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three nonsense mutations responsible for group A xeroderma pigmentosum.
    Satokata I; Tanaka K; Miura N; Narita M; Mimaki T; Satoh Y; Kondo S; Okada Y
    Mutat Res; 1992 Mar; 273(2):193-202. PubMed ID: 1372102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.v.-hypermutability of xeroderma pigmentosum cells demonstrated with a DNA-based mutation system.
    Steingrimsdottir H; Beare D; Carr AM; Cole J; Lehmann AR
    Oncogene; 1995 May; 10(10):2057-66. PubMed ID: 7761106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells.
    McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K
    Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of the clinical manifestations and gene mutations of Japanese xeroderma pigmentosum group A patients.
    Kondoh M; Ueda M; Ichihashi M
    Br J Dermatol; 1995 Oct; 133(4):579-85. PubMed ID: 7577588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.